I still find it sad that a huge amount of effort was put into testing two drugs based on bad initial data. Both Hydroxychloroquine and Ivermectin simply were ne

I still find it sad that a huge amount of effort was put into testing two drugs based on bad initial data. Both Hydroxychloroquine and Ivermectin simply were never as promising as some people claimed, but both pretty much hijacked the entire pipeline of drug trials for COVID based on their popularity and political factors. This was maybe more extreme with Hydroxychloroquine, but there it also affected other trials as people were hesitant to offer them without it based on it's undeserved reputation. Of course some trials on both were reasonable and useful to do, but if you divert that many resources based on not very promising initial data you are likely hurting efforts to study other, more promising leads.